BlackRock Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $233M | Buy |
634,545
+18,328
| +3% | +$6.73M | 0.11% | 221 |
|
|
2016
Q3 | $248M | Buy |
616,217
+17,764
| +3% | +$7.14M | 0.12% | 194 |
|
|
2016
Q2 | $209M | Buy |
598,453
+15,934
| +3% | +$5.56M | 0.11% | 227 |
|
|
2016
Q1 | $210M | Sell |
582,519
-20,846
| -3% | -$7.51M | 0.11% | 203 |
|
|
2015
Q4 | $328M | Sell |
603,365
-9,885
| -2% | -$5.37M | 0.18% | 131 |
|
|
2015
Q3 | $285M | Sell |
613,250
-51,051
| -8% | -$23.7M | 0.17% | 140 |
|
|
2015
Q2 | $339M | Buy |
664,301
+29,841
| +5% | +$15.2M | 0.18% | 119 |
|
|
2015
Q1 | $286M | Sell |
634,460
-3,545
| -0.6% | -$1.6M | 0.15% | 147 |
|
|
2014
Q4 | $262M | Buy |
638,005
+30,831
| +5% | +$12.6M | 0.14% | 168 |
|
|
2014
Q3 | $219M | Sell |
607,174
-24,762
| -4% | -$8.93M | 0.13% | 183 |
|
|
2014
Q2 | $179M | Buy |
631,936
+53,466
| +9% | +$15.1M | 0.1% | 236 |
|
|
2014
Q1 | $174M | Buy |
578,470
+40,664
| +8% | +$12.2M | 0.11% | 221 |
|
|
2013
Q4 | $148M | Sell |
537,806
-28,907
| -5% | -$7.96M | 0.1% | 242 |
|
|
2013
Q3 | $177M | Buy |
566,713
+48,085
| +9% | +$15M | 0.12% | 190 |
|
|
2013
Q2 | $117M | Buy |
+518,628
| New | +$117M | 0.09% | 258 |
|